A novel population of Gr-1+-activated macrophages induced during acute toxoplasmosis

Journal of Leukocyte Biology

Volumn 74, Issue 6, 2003, Pages 1015-1025

  Mordue, Dana G ^a,b   Sibley, L David ^a,c  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c Box 8230 ^*  (United States)

Author keywords

Cellular activation; Dendritic cells; Host defense; Intracellular pathogen; Neutrophils

Indexed keywords

CD11B ANTIGEN; CD31 ANTIGEN; CELL MARKER; GLYCOPROTEIN P 15095; INTERLEUKIN 12; NITROGEN; PROTEIN P40;

ACUTE DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; BONE MARROW CELL; CELL MATURATION; CELL POPULATION; CELL TYPE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DENDRITE; DISEASE SEVERITY; EFFECTOR CELL; FEMALE; GRANULOCYTE; HISTOCOMPATIBILITY COMPLEX; IN VITRO STUDY; MACROPHAGE; MOUSE; NEUTROPHIL; NONHUMAN; PERITONEAL CAVITY; PERITONEUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROVOCATION TEST; TOXOPLASMA GONDII; TOXOPLASMOSIS;

ACUTE DISEASE; ANIMALS; ANTIGENS, CD; B-LYMPHOCYTES; BIOLOGICAL MARKERS; DENDRITIC CELLS; GRANULOCYTES; HISTOCOMPATIBILITY ANTIGENS CLASS II; INTERLEUKIN-12; MACROPHAGE ACTIVATION; MACROPHAGES, PERITONEAL; MICE; MYELOID CELLS; TOXOPLASMA; TOXOPLASMOSIS, ANIMAL;

ANIMALIA; PROTOZOA; TOXOPLASMA GONDII;

EID: 0347416900     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0403164     Document Type: Article

References (62)

1. Dubey, J. P., Beattie, C. P. (1988) Toxoplasmosis of Animals and Man, Boca Raton, FL, CRC.
2. Dubey, J. P., Lindsay, D. S., Speer, C. A. (1998) Structures of Toxoplasma gondii tachyzoites, bradyzoites and sporozoites and biology and development of tissue cysts. Clin. Microbiol. Rev. 11, 267-299.
3. Luft, B. J., Brooks, R. G., Conley, F. G., McCabe, R. E., Remington, J. S. (1984) Toxoplasmic encephalitis in patients with acquired immunodeficiency syndrome. JAMA 252, 913-917.
4. Howe, D. K., Sibley, L. D. (1995) Toxoplasma gondii comprises three clonal lineages: correlation of parasite genotype with human disease. J. Infect. Dis. 172, 1561-1566.
5. Sibley, L. D., Boothroyd, J. C. (1992) Virulent strains of Toxoplasma gondii comprise a single clonal lineage. Nature 359, 82-85.
6. Howe, D. K., Summers, B. C., Sibley, L. D. (1996) Acute virulence in mice is associated with markers on chromosome VIII in Toxoplasma gondii. Infect. Immun. 64, 5193-5198.
7. Su, C., Howe, D. K., Dubey, J. P., Ajioka, J. W., Sibley, L. D. (2002) Identification of quantitative trait loci controlling acute virulence in Toxoplasma gondii. Proc. Natl. Acad. Sci. USA 99, 10753-10758.
8. Barragan, A., Sibley, L. D. (2002) Transepithelial migration of Toxoplasma gondii is linked to parasite motility and virulence. J. Exp. Med. 195, 1625-1633.
9. Mordue, D. G., Monroy, F., La Regina, M., Dinarello, C. A., Sibley, L. D. (2001) Acute toxoplasmosis leads to lethal overproduction of Th1 cytokines. J. Immunol. 167, 4574-4584.
10. Blackwell, J. M., Roberts, C. W., Alexander, J. (1993) Influence of genes within the MHC on mortality and brain cyst development in mice infected with Toxoplasma gondii: kinetics of immune regulation in BALB H-2 congenic mice. Parasite Immunol. 15, 317-324.
11. + T cells determine cyst number in Toxoplasma gondii infection. J. Immunol. 145, 3438-3441.
12. McLeod, R., Skamene, E., Brown, C. R., Eisenhauer, P. B., Mack, D. G. (1989) Genetic regulation of early survival anti cyst number after peroral Toxoplasma gondii infection of AxB/BxA recombinant inbred and B10 congenic mice. J. Immunol. 143, 3031-3034.
13. McLeod, R., Mack, D. G., Boyer, K., Mets, M., Roizen, N., Swisher, C., Patel, D., Beckmann, E., Vitullo, D., Johnson, D., Meier, P. (1990) Phenotypes and functions of lymphocytes in congenital toxoplasmosis. J. Lab. Clin. Med. 116, 623-635.
14. Fuentes, I., Rubio, J. M., Ramírez, C., Alvar, J. (2001) Genotypic characterization of Toxoplasma gondii strains associated with human toxoplasmosis in Spain: direct analysis from clinical samples. J. Clin. Microbiol. 39, 1566-1570.
15. Grigg, M. E., Boothroyd, J. C. (2001) Rapid identification of virulent type I strains of the protozoan parasite Toxoplasma gondii by PCR-restriction fragment length polymorphism analysis of the B1 gene. J. Clin. Microbiol. 39, 398-400.
16. Howe, D. K., Honoré, S., Derouin, F., Sibley, L. D. (1997) Determination of genotypes of Toxoplasma gondii strains isolated from patients with toxoplasmosis. J. Clin. Microbiol. 35, 1411-1414.
17. Deckert-Schlüter, M., Rang, A., Wether, D., Huang, S., Wiestler, O. D., Hof, H., Schlüter, D. (1996) Interferon-γ receptor-deficiency renders mice highly susceptible to toxoplasmosis by decreased macrophage activation. Lab. Invest. 75, 827-841.
18. Suzuki, Y., Orellana, M. A., Schreiher, R. D., Remington, J. S. (1988) Interferon-γ: the major mediator of resistance against Toxoplasma gondii. Science 240, 516-518.
19. Yap, G. S., Sher, A. (1999) Effector cells of both nonhemopoietic and hemopoietic origin are required for interferon (IFN)-γ- and tumor necrosis factor (TNF)-α-dependent host resistance to the intracellular pathogen, Toxoplasma gondii. J. Exp. Med. 189, 1083-1091.
20. Collazo, C. M., Yap, G. S., Sempowski, G. D., Lusby, K. C., Tessarullo, L., Woude, G. F., Sher, A., Taylor, G. A. (2001) Inactivation of LRG-47 and IRG-47 reveals a family of interferon γ-inducible genes with essential, pathogen-specific rules in resistance to infection. J. Exp. Med. 194, 181-188.
21. Taylor, G. A., Collazo, C. M., Yap, G. S., Nguyen, K., Gregorio, T. A., Taylor, L. S., Eagleson, B., Secrest, L., Southon, E. A., Reid, S. W., Tessarollo, L., Bray, M., McVicar, D. W., Komschlies, K. L., Young, H. A., Biron, C. A., Sher, A., Vande Woude, G. F. (2000) Pathogen-specific lass of host resistance in mice lacking IFN-γ-inducible gene IGTP. Proc. Nat. Acad. Sci. USA 97, 751-755.
22. Scharton-Kersten, T. M., Wynn, T. A., Denkers, E. Y., Bala, S., Grunvald, E., Hieny, S., Gazzinelli, R. T., Sher, A. (1996) In the absence of endogenous IFN-γ mice develop unimpaired IL-12 responses to Toxoplasma gondii while failing to control acute infection. J. Immunol. 157, 4045-4054.
23. Bliss, S. K., Zhang, Y., Denkers, E. Y. (1999) Murine neutrophil stimulation by Toxoplasma gondii antigen drives high level production of IFN-γ-independent IL-12. J. Immunol. 163, 2081-2088.
24. Sousa, C. R., Hieny, S., Scharton-Kersten, T., Jankovic, D., Charest, H., Germain, R. N., Sher, A. (1997) In vivo microbial stimulation induces rapid CD40 ligan-independent production of interleukin 12 by dendritic cells and their redistribution to T cell areas. J. Exp. Med. 186, 1819-1829.
25. Hunter, C. A., Subauste, C. S., Van Cleave, V. H., Remington, J. S. (1994) Production of gamma interferon by natural killer cells from Toxoplasma gondii-infected SCID mice: regulation by interleukin-10, interleukin-12, and tumor necrosis factor alpha. Infect. Immun. 62, 2818-2824.
26. Sher, A., Oswald, I. P., Hieny, S., Gazzinelli, R. T. (1993) Toxoplasma gondii induces a T-independent IFN-γ response in natural killer cells that requires both adherent accessory cells anti tumor necrosis factor-α. J. Immunol. 150, 3982-3989.
27. Bliss, S. K., Butcher, B. A., Denkers, E. Y. (2000) Rapid recruitment of neutrophils containing prestored IL-12 during microbial infection. J. Immunol. 165, 4515-4521.
28. Bliss, S. K., Gavrilescu, L. C., Alcaraz, A., Denkers, E. Y. (2001) Neutrophil depletion during Toxoplasma gondii infection leads to impaired immunity anti lethal systemic pathology. Infect. Immun. 69, 4898-4905.
29. Del Rio, L., Bennouna, S., Salinas, J., Denkers, E. Y. (2001) CXCR2 deficiency confers impaired neutrophil recruitment and increased susceptibility during Toxoplasma gondii infection. J. Immunol. 167, 6503-6509.
30. Derouin, F., Garin, Y. J. F. (1991) Toxoplasma gondii: blood and tissue kinetics during acute and chronic infections in mice. Exp. Parasitol. 73, 460-468.
31. Dubey, J. P. (1997) Bradyzoite-induced murine toxoplasmosis: stage conversion, pathogenesis, and tissue cyst formation in mice fed bradyzoites of different strains of Toxoplasma gondii. J. Eukaryot. Microbiol. 44, 592-602.
32. Zenner, L., Darcy, F., Capron, A., Cesbron-Delauw, M. F. (1998) Toxoplasma gondii: kinetics of the dissemination in the host tissues (luring the acute phase of infection in rats and mice. Exp. Parasitol. 90, 86-94.
33. Sabin, A. B. (1941) Toxoplasmic encephalitis in children. J. Am. Med. Assoc. 116, 801-807.
34. Ware, P. L., Kasper, L. H. (1987) Strain-specific antigens of Toxoplasma gondii. Infect. Immun. 55, 778-783.
35. Corraliza, I. M., Campo, M. L., Soler, G., Modolell, M. (1994) Determination of arginase activity in macrophages: a micromethod. J. Immunol. Methods 174, 231-235.
36. Mordue, D. G., Sibley, L. D. (1997) Intracellular fate of vacuoles containing Toxoplasma gondii is determined at the time of formation and depends on the mechanism of entry. J. Immunol. 159, 4452-4459.
37. McKnight, A. J., Gordon, S. (1998) Membrane molecules as differentiation antigens of murine macrophages. Adv. Immunol. 68, 271-314.
38. Fanger, N. A., Liu, C., Guyre, P. M., Wardwell, K., O'Neil, J., Guo, T. L., Christian, T. P., Mudzinski, S. P., Gosselin, E. J. (1997) Activation of human T cells by major histocompatibility complex class II expressing neutrophils: proliferation in the presence of superantigen, but not tetanus toxoid. Blood 89, 4128-4135.
39. McLeod, R., Eisenhauer, P., Mack, D., Felice, G., Spitalny, G. (1989) Immune responses associated with early survival after peroral infection with Toxoplasma gondii. J. Immunol. 142, 3247-3255.
40. Buzoni-Gatel, D., Debbabi, H., Moretto, M., Dimier-Poisson, I. H., Lepage, A. C., Bout, D. T., Kasper, L. H. (1999) Intraepithelial lymphocytes traffic to the intestine and enhance resistance to Toxoplasma gondii oral infection. J. Immunol. 162, 5846-5852.
41. + T lymphocytes synergize with murine intestinal epithelial cells to enhance proinflammatory response against an intracellular pathogen. J. Immunol. 168, 2988-2996.
42. Goerdt, S., Orfanos, C. E. (1999) Other functions, other genes: alternative activation of antigen-presenting cells. Immunity 10, 137-142.
43. Mills, C. (2001) Macrophage arginine metabolism to ornithine/urea or nitric oxide/citrulline: a life or death issue. Crit. Rev. Immunol. 21, 399-425.
44. Hammerman, J. A., Adarem, A. (2001) Functional transitions in macrophages during in vivo infection with Mycobacterium bovis bacillus Calmette-Guerin. J. Immunol. 167, 2227-2233.
45. Drapier, J. C., Weitzerbin, J., Hibbs, J. B. (1988) Interferon-γ and minor necrosis factor induce the L-arginine-dependent cytotoxic effector mechanism in murine macrophages. Eur. J. Immunol. 18, 1587-1592.
46. Khan, I. A., Schwartzman, J. D., Matsuura, T., Kasper, L. H. (1997) A dichotomous role for nitric oxide during acute Toxoplasma gondii infection in mice. Proc. Natl. Acad. Sci. USA 94, 13955-10960.
47. Scharton-Kersten, T. M., Yap, G., Magram, J., Sher, A. (1997) Inducible nitric oxide is essential for host control of persistent but not acute infection with the intracellular pathogen Toxoplasma gondii. J. Exp. Med. 185, 1261-1273.
48. Lüder, C. G., Walter, W., Beuerle, B., Maeurer, M. J., Gross, U. (2001) Toxoplasma gondii down-regulates MHC class II gene expression and antigen presentation by murine macrophages via interference with nuclear translocation of STAT1α. Eur. J. Immunol. 31, 1475-1484.
49. Lüder, C. G. K., Lang, T., Beuerle, B., Gross, U. (1998) Down-regulation of MHC class II molecules anti inability to up-regulate class I molecules in murine macrophages after infection with Toxoplasma gondii. Clin. Exp. Immunol. 112, 308-316.
50. Sibley, L. D., Adams, L. B., Fukutomi, Y., Krahenbuhl, J. L. (1991) Tumor necrosis factor-a riggers antitoxoplasmal activity of IFN-γ primed macrophages. J. Immunol. 147, 2340-2345.
51. Radke, J. R., Striepen, B., Guerini, M. N., Jeanne, M. E., Roos, D. S., White, M. W. (2001) Defining the cell cycle for the tachyzoite stage of Toxoplasma gondii. Mol. Biochem. Parasitol. 115, 165-175.
52. Gazzinelli, R. T., Heiny, S., Wynn, T. A., Wolf, S., Sher, A. (1993) Interleukin 12 is required for the T-lymphocyte-independent induction of interferon γ by an intracellular parasite and induces resistance in T-cell-deficient mice. Proc. Natl. Acad. Sci. USA 90, 6115-6119.
53. Khan, I. A., Matsuura, T., Kasper, L. H. (1994) Interleukin-12 enhances murine survival against acute toxoplasmosis. Infect. Immun. 62, 1639-1642.
54. Yap, G., Pesin, M., Sher, A. (2000) Cutting edge: IL-12 is required for the maintenance of IFN-γ production in T cells mediating chronic resistance to the intracellular pathogen, Toxoplasma gondii. J. Immunol. 165, 628-631.
55. Brombacher, F., Kastelein, R. A., Alber, G. (2003) Novel IL-12 family members shed light on the orchestration of Th1 responses. Trends Immunol. 24, 207-212.
56. Trinchieri, G. (2003) Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat. Rev. Immunol. 3, 133-146.
57. Atochina, O., Daly-Engel, T., Piskorska, D., McGuire, E., Harn, D. A. (2001) A Schistosome-expressed immunomodulatory glycoconjugate expatois peritoneal Gr-1+ macrophages that suppress naive CD4+ T cell proliferation via an IFN-γ and nitric oxide dependent mechanism. J. Immunol. 167, 4293-4302.
58. Gabrilovich, D. I., Velders, M. P., Sotomayor, E. M., Kast, W. M. (2001) Mechanism of immune dysfunction in cancer mediated})y immature Gr-1+ myeloid cells. J. Immunol. 166, 5398-5406.
59. Henderson, R. B., Hobbs, J. A. R., Mathies, M., Hogg, N. (2003) Rapid recruitment of inflammatory monocytes is independent of neutrophil migration. Blood 102, 328-335.
60. Geissmann, F., Jung, S., Litman, D. R. (2003) Blood monocytes consist of two print]pie subsets with distinct migratory properties, Immunity 19, 71-82.
61. Nakano, H., Yanagita, M., Dee Gunn, M. (2001) CD11c+ B220+ Gr-1+ cells in mouse lymph nodes anti spleen display characteristics of plasmacytoid dendritic cells. J. Exp. Med. 194, 1171-178.
62. Hestdal, K., Ruscetti, F. W., Ihle, J. N., Jacobsen, S. E., Dubois, C. M., Kopp, W. C., Longo, D. L., Keller, J. R. (1991). Characterization and regulation of RB6-8C5 antigen expression on murine bone marrow cells. J. Immunol. 147, 22-28.